SeerPharma Supporting BioSymposium on Modernising Clinical Trials

For over 35 years, SeerPharma has been at the forefront of advancing Quality and GMP best practices within the pharmaceutical and medical device sectors. Our clients span the full product lifecycle—from early-stage clinical trials through to international market distribution.

Over the past 10–15 years, Australia has emerged as a leading destination for global clinical trials. In parallel, we have seen increasing demand for our expertise in supporting:

• The establishment and digital transformation of Quality Management Systems (QMS)
• Advisory services to obtain relevant GMP licences for Clinical Research Organisations (CROs), Clinical Trial Manufacturers, and logistics providers
• Independent assessments and audits (e.g. GCP, GLP, GMP) for organisations involved in clinical trial activity

In line with this growing momentum, SeerPharma is proud to be sponsoring and presenting at the upcoming BioSymposium: Modernising Clinical Trials, hosted by BioMelbourne Network.

The event will be held on Tuesday, the 16th of September, and will shine a spotlight on this integral part of our industry.

The BioSymposium will explore how clinical trials can be modernised to improve execution, expand access, and increase impact - both for patients and the Australian economy – and capitalise on this pivotal period in the evolution of clinical research.

The program features four high-impact sessions filled with practical insights and encouraging collaborative problem-solving:

1. Clinical trials for what outcome?
2. Industry dialogue - designing better trials
3. Decentralised trials - practical boundaries and future directions
4. The trial journey - opportunities for better outcomes

For more information and to register for this marquee event, visit: https://biomelbournenetwork.zohobackstage.com/BioSymposium-ModernisingclinicaltrialsExecutionaccessandimpact